Advertisement

Topics

Clinical Development & Administration Incorporated Company Profile

20:04 EDT 20th September 2018 | BioPortfolio

Clinical Development & Administration, Inc. (ClinDev) is one of the world's fastest growing niche contract research organizations. Clinical research services include project facilitation and management, contract staffing, investigational site management, and process advising. Review ClinDev Online to learn how ClinDev provides the global pharmaceutical industry with innovative solutions for accelerated clinical development.

Location

70 East Lake Street, Suite 530
Chicago
IL
60601-5907
United States of America

Contact

Phone: 312 251 4580
Fax: 312 251 3109
Email: investigators@clindev.com


News Articles [2136 Associated News Articles listed on BioPortfolio]

Progress on Pacritinib Development for Treatment of Myelofibrosis

CancerConnect News: The full clinical hold implemented by the U.S. Food and Drug Administration (FDA) on all clinical trials conducted […] The post Progress on Pacritinib Development for Treatme...

Synthetic Biologics provides update on development of ribaxamase for prevention of C. difficile infection

Synthetic Biologics, Inc., a late─stage clinical company, announced that it has preliminary agreement from the US Food & Drug Administration (FDA), on a proposed clinical trial synopsis for its pla...

Zimmer BioTech expands development team

In Dr. Reinhold Gahlmann and Stuart Marcus, Neu-Ulm-based Zimmer BioTech has now hired two experts in the field of pharmaceutical development. As Head of Clinical Development, Dr. Gahlmann will be res...

Zynerba Scraps Development of THC Prodrug ZYN001 after Failed Trial

Cannabinoid-based drug developer Zynerba Pharmaceuticals said today it will halt development of its D-glyceric acid ester-delta-9-tetrahydrocannabinol (THC) prodrug candidate ZYN001 following its fail...

Lynparza Clinical Development Timeline

Chronicle of the development and US FDA review of AstraZeneca's olaparib in ovarian cancer (with and without a companion diagnostic...   

[Comment] When a negative trial in ALS has a positive effect on research

In the past 5 years, amazing progress has been made in the development of therapies for amyotrophic lateral sclerosis (ALS). New genetic causes have been identified, including the C9orf72 hexanucleoti...

Idhifa Clinical Development Timeline

Chronicle of development and US FDA review of Celgene and Agios' enasidenib for relapsed or refractory acute myelogenous leukemia harboring...   

Lutathera Clinical Development Timeline

Chronicle of the development and US FDA review of Advanced Accelerator Applications' lutetium Lu 177 dotatate for gastroenteropancreatic neuroendocrine tumors.   

PubMed Articles [4935 Associated PubMed Articles listed on BioPortfolio]

Helping veterans achieve work: A Veterans Health Administration nationwide survey examining effective job development practices in the community.

Veterans Health Administration vocational services assist veterans with mental illness to acquire jobs; one major component of these services is job development. The purpose of this study was to chara...

Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia
.

Angiotensin receptor blockers (ARBs) are often used in patients on paclitaxel (PTX) and carboplatin combination (TC) therapy to treat hypertension caused by the co-administration of bevacizumab. The a...

Conflicting priorities: observation of medicines administration.

To identify sources of interruptions and distractions to medicine administration rounds in hospitals.

Subcutaneous delivery of monoclonal antibodies: How do we get there?

The convenience of subcutaneous (SC) administration and the increase of monoclonal antibodies (mAbs) being studied for chronic diseases disclose that their potential to be delivered through SC injecti...

Endomorphin-1 analogs with oligoarginine-conjugation at C-terminus produce potent antinociception with reduced opioid tolerance in paw withdrawal test.

For clinical use, it is essential to develop potent endomorphin (EM) analogs with reduced antinociceptive tolerance. In the present study, the antinociceptive activities and tolerance development of f...

Clinical Trials [5891 Associated Clinical Trials listed on BioPortfolio]

Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics

The aim of the study is to elucidate the relationship between postnatal antibiotic administration on development of gut microbiota and possible protective influence of simultaneously admin...

Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle

We hypothesize that administration of OCs at varying follicular diameters will provide an appropriate model for the study of follicular atresia in women. Clinically, we hypothesize that t...

Clinical Trial of ARQ 761 in Advanced Solid Tumors

Primary Objective: To determine the safety, tolerability and recommended Phase 2 dose (RP2D) of ARQ 761 administered intravenously. Secondary Objectives: To determine the ph...

Clinical Investigation Plan for the AVOPT Data Collection Clinical Study

The purpose of this study is to collect clinical data for the development and evaluation of a new device feature for automatic AV-delay (AVD) optimization.

Study Evaluating Intervention in the Development of Clinical Research in Non-Academic Health Institution (ERNU)

This study evaluates the interventions of the Cancéropôle Nord-Ouest in the development of clinical research in non-academic health institution. The randomization, in open label,determin...

Companies [3538 Associated Companies listed on BioPortfolio]

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Clinical Development & Administration Incorporated

Clinical Development & Administration, Inc. (ClinDev) is one of the world's fastest growing niche contract research organizations. Clinical research services include project facilitation and manageme...

Praecis Pharmaceuticals Incorporated (MA)

PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAP™ (Ligand Evolution to Active Pharmaceut...

InteKrin Therapeutics Inc.

InteKrin Therapeutics is a privately-held clinical-stage drug development company focused on diabetes, obesity and metabolic disease. InteKrin's business strategy is to build a robust portfolio of hig...

InteKrin Therapeutics, Inc.

InteKrin Therapeutics is a privately-held clinical-stage drug development company focused on diabetes, obesity and metabolic disease. InteKrin's business strategy is to build a robust portfolio of hig...

More Information about "Clinical Development & Administration Incorporated" on BioPortfolio

We have published hundreds of Clinical Development & Administration Incorporated news stories on BioPortfolio along with dozens of Clinical Development & Administration Incorporated Clinical Trials and PubMed Articles about Clinical Development & Administration Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clinical Development & Administration Incorporated Companies in our database. You can also find out about relevant Clinical Development & Administration Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record